Literature DB >> 20972719

Nitric oxide inhibits ghrelin-induced cell proliferation and ERK1/2 activation in GH3 cells.

Chunlei Tian1, Fei Ye, Lei Wang, Yuanguo Deng, Yuanxun Dong, Xiaodan Wang, Tongjiang Xu, Ting Lei, Xiongwei Wang.   

Abstract

Ghrelin stimulates growth hormone release and cell proliferation, which strongly supports a significant role for this peptide in the control of growth hormone-releasing adenomas function and growth. Nitric oxide can influence the stimulatory effects of ghrelin on growth hormone secretion in growth hormone-releasing adenomas. However, the effect of nitric oxide (NO) on ghrelin-induced cell proliferation and the mechanism of this effect in the adenoma were not clarified. In this study, we observed that ghrelin, at a concentration of 10⁻⁹ to 10⁻⁶ M, significantly increased BrdU incorporation into rat GH3 cells. A NO donor, S-nitroso-N-acetylpenicillamine (SNAP), blunted basal, and ghrelin-induced cell proliferation. A blocker of NO synthase, Nw-nitro-L-arginine methyl ester hydrochloride (NAME), had no influence on these actions. The activation of extracellular signal-regulated kinase (ERK) 1/2 was examined by western blotting. The results showed that SNAP reduced ghrelin-stimulated ERK1/2 activation but NAME had no influence on this activation. Together, this study indicates that NO inhibited ghrelin-induced cell proliferation by blocking ERK1/2 activation in GH3 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972719     DOI: 10.1007/s12020-010-9402-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

Review 1.  NO-cGMP signaling and regenerative medicine involving stem cells.

Authors:  K S Madhusoodanan; Ferid Murad
Journal:  Neurochem Res       Date:  2006-10-18       Impact factor: 3.996

2.  Endogenous nitric oxide inhibits growth hormone secretion through cyclic guanosine monophosphate-dependent mechanisms in GH3 cells.

Authors:  M Tsumori; Y Murakami; K Koshimura; Y Kato
Journal:  Endocr J       Date:  1999-12       Impact factor: 2.349

3.  Influence of nitric oxide on hypoglycemia--or angiotensin II-stimulated ACTH and GH secretion in normal men.

Authors:  R Volpi; P Chiodera; G Caffarri; P P Vescovi; L Capretti; C Gatti; V Coiro
Journal:  Neuropeptides       Date:  1996-12       Impact factor: 3.286

Review 4.  International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function.

Authors:  Anthony P Davenport; Tom I Bonner; Steven M Foord; Anthony J Harmar; Richard R Neubig; Jean-Philippe Pin; Michael Spedding; Masayasu Kojima; Keniji Kangawa
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway.

Authors:  F Rodríguez-Pacheco; R M Luque; M Tena-Sempere; M M Malagón; J P Castaño
Journal:  J Neuroendocrinol       Date:  2008-01-15       Impact factor: 3.627

7.  Tumor necrosis factor-alpha-induced nitric oxide restrains the apoptotic response of anterior pituitary cells.

Authors:  Marianela Candolfi; Gabriela Jaita; Verónica Zaldivar; Sandra Zárate; Daniel Pisera; Adriana Seilicovich
Journal:  Neuroendocrinology       Date:  2004-10-06       Impact factor: 4.914

8.  Activation of p38 mitogen-activated protein kinase (p38 MAPK), extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of guinea pig fetus at term: role of nitric oxide.

Authors:  Dev Maulik; Qazi M Ashraf; Om P Mishra; Maria Delivoria-Papadopoulos
Journal:  Neurosci Lett       Date:  2008-02-26       Impact factor: 3.046

9.  Role of nitric oxide in control of prolactin release by the adenohypophysis.

Authors:  B H Duvilanski; C Zambruno; A Seilicovich; D Pisera; M Lasaga; M C Diaz; N Belova; V Rettori; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

Review 10.  What is the real physiological NO concentration in vivo?

Authors:  Catherine N Hall; John Garthwaite
Journal:  Nitric Oxide       Date:  2009-07-12       Impact factor: 4.427

View more
  1 in total

1.  Correlation of ghrelin and growth hormone secretagogue receptor expression with clinical features in human pituitary adenomas.

Authors:  Junwen Wang; Songbo Guo; Lin Han; Mingbo Fang; Lei Wang; Jörg W Bartsch; Jun Li
Journal:  Exp Ther Med       Date:  2015-03-11       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.